135 related articles for article (PubMed ID: 10498878)
1. Acute promyelocytic leukemia: from treatment to genetics and back.
Kogan SC; Bishop JM
Oncogene; 1999 Sep; 18(38):5261-7. PubMed ID: 10498878
[No Abstract] [Full Text] [Related]
2. [Leukemia specific chimeric protein as a target molecule for chemotherapy].
Naoe T
Rinsho Ketsueki; 1998 Feb; 39(2):105-6. PubMed ID: 9545811
[No Abstract] [Full Text] [Related]
3. Identification of a complex (11;17;15) translocation in acute promyelocytic leukemia.
Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
Cancer Genet Cytogenet; 2005 Nov; 163(1):93-4. PubMed ID: 16271965
[No Abstract] [Full Text] [Related]
4. Pituitary relapse of acute promyelocytic leukemia after ATRA.
Lugassy G; Halperin Y
Int J Hematol; 1998 Jul; 68(1):101-2. PubMed ID: 9713174
[No Abstract] [Full Text] [Related]
5. Tretinoin in the treatment of acute promyelocytic leukemia.
Wong WM
Cancer Pract; 1996; 4(4):220-3. PubMed ID: 8900766
[No Abstract] [Full Text] [Related]
6. Acute promyelocytic leukemia: new issues on pathogenesis and treatment response.
Vitoux D; Nasr R; de The H
Int J Biochem Cell Biol; 2007; 39(6):1063-70. PubMed ID: 17468032
[TBL] [Abstract][Full Text] [Related]
7. Long-term seventh molecular remission in acute promyelocytic leukaemia.
Cicconi L; Romano A; Ramadan SM; Divona M; Petti MC; Lo-Coco F
Ann Hematol; 2011 Nov; 90(11):1369-70. PubMed ID: 21336626
[No Abstract] [Full Text] [Related]
8. Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors.
Avvisati G; Lo Coco F; Mandelli F
Semin Hematol; 2001 Jan; 38(1):4-12. PubMed ID: 11172535
[TBL] [Abstract][Full Text] [Related]
9. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications.
He LZ; Merghoub T; Pandolfi PP
Oncogene; 1999 Sep; 18(38):5278-92. PubMed ID: 10498880
[TBL] [Abstract][Full Text] [Related]
10. [Apropos of a case of acute leukemia].
Vincenot A; Buret B; Allard C
Ann Biol Clin (Paris); 1997; 55(4):339-40. PubMed ID: 9309235
[No Abstract] [Full Text] [Related]
11. Development and overcoming of ATRA resistance in acute promyelocytic leukemia.
Lo Coco F
Haematologica; 1999 Nov; 84(11):961-2. PubMed ID: 10553153
[No Abstract] [Full Text] [Related]
12. All-trans retinoic acid related headache in patients with acute promyelocytic leukemia: prophylaxis and treatment with acetazolamide.
Ganguly S
Leuk Res; 2005 Jun; 29(6):721. PubMed ID: 15863216
[No Abstract] [Full Text] [Related]
13. ATRA-induced myositis in induction therapy of acute promyelocytic leukemia.
Martínez-Chamorro C; Martínez E; Gil-Fernández JJ; Alonso A; Escudero A; Fernández-Rañada JM
Haematologica; 2002 Feb; 87(2):ECR08. PubMed ID: 11836177
[No Abstract] [Full Text] [Related]
14. Scrotal ulcerations during all-transretinoic acid therapy for acute promyelocytic leukemia.
Ramzi J; Hend BN; Lamia A; Raihane BL; Hela BA; Zaher BA; Balkis M
Ann Hematol; 2007 Apr; 86(4):289-90. PubMed ID: 17205289
[No Abstract] [Full Text] [Related]
15. The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia.
Zhang P
J Biol Regul Homeost Agents; 1999; 13(4):195-200. PubMed ID: 10703942
[TBL] [Abstract][Full Text] [Related]
16. Repeated efficacy of all-trans-retinoic acid in an acute promyelocytic leukemia patient.
Watanabe A; Inokuchi K; Mizuki T; Yamaguchi H; Yokose N; Dan K
Am J Hematol; 2000 Sep; 65(1):87-8. PubMed ID: 10936873
[No Abstract] [Full Text] [Related]
17. Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review.
Bao L; Lu X; Lai Y; Zhang X; Zhu H; Liu Y; Qin Y; Huang XJ
Leuk Res; 2009 Jul; 33(7):e64-8. PubMed ID: 19297021
[No Abstract] [Full Text] [Related]
18. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
Naeem M; Harrison K; Barton K; Nand S; Alkan S
Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
[TBL] [Abstract][Full Text] [Related]
19. [Lessons learned from differentiation therapy with all-trans retinoic acid in the JALSG APL studies].
Asou N
Rinsho Ketsueki; 2004 Feb; 45(2):115-24. PubMed ID: 15045819
[No Abstract] [Full Text] [Related]
20. Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemia.
Gallipoli P; Drummond MW
Eur J Haematol; 2009 Mar; 82(3):242-3. PubMed ID: 19018859
[No Abstract] [Full Text] [Related]
[Next] [New Search]
